IRadimed Corporation Awarded Single Source Novation Contract for Its MRidium™ MRI IV Pump System with Integrated Masimo SET SpO2 and Dose Error Reduction System

WINTER PARK, Fla., June 4, 2012 /PRNewswire/ -- Novation, the largest health care supply contracting company in the United States, has awarded IRadimed Corporation a three-year single source contract for its MRidium™ MRI Infusion Pump Systems. Effective September 1st, 2012, the agreement makes the MRidium™ Systems available to all 65,000 VHA, UHC and Provista members served by Novation. MRidium was awarded the contract under Novation's MR Compatible IV Pump category. This new agreement offers a broad base of new customers for IRadimed to partner with and grow its current strong base of MRidium MRI Infusion Pumps in the US Market. 

The MRidium™ Systems are the only Non Magnetic IV Pumps designed specifically for use in the MRI Environment. Safety in the MR is the primary concern when it comes to meeting needs for required patient care. These risks are well known: equipment can fly into the MR, cause artifacts on the images of the scan, or just shut down during crucial deliveries of medications and monitoring. "It is critical to have products which have been designed with the utmost care and thorough insight of this harsh and potentially dangerous environment," said Roger Susi, President and founder of IRadimed Corporation.

The MRidium 3860 MRI Infusion System also incorporates Masimo's SET SpO2 System for continuous monitoring of patients from the ICU, NICU, Neurology, and other areas of the hospital right into the MRI Suite. The 3860 System also offers an expanded drug library with DERS (Dose Error Reduction System), which helps prevent medication entry errors while programming infusions, and provides the patient safety features that are quickly becoming the standard in infusion therapy in general patient care areas. 

The MRidium™ System also supports infusion delivery in the MR through additional accessories associated with the MRI Infusion Pump. The system offers a modular second channel, which when attached to the 3860 Pump, allows for delivery of two medications simultaneously during patient scans. An optional fully featured wireless remote control monitor is also available that has true plug and play capabilities, requiring no installation. A full range of available infusion sets are also available to provide the clinical flexibility needed in the demanding MRI environment. 

About IRadimed Corporation

IRadimed Corporation is a leader in MRI safe products and Infusion Therapy. Our founder is the pioneering developer of both the world's first and best selling MRI compatible monitoring system and the only Non Magnetic IV Pumps designed specifically for use in the MRI Environment. IRadimed's staff has a combined 70+ years developing MRI safe products. The MRidium™ Infusion System has full benefit of the experience and attention to details so important to the development of quality equipment which can be safely used in the MRI setting. For more information, please visit www.iradimed.com.

MRidium is a Trademark of IRadimed Corporation

About Novation, Winner of the Ethics Inside® Certification

Founded in 1998, Novation is the leading health care supply contracting company for the more than 65,000 members of VHA Inc. and UHC, two national health care alliances, and Provista, LLC. Novation provides alliance members sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC and Provista members used Novation contracts to purchase more than $40 billion in 2011. Novation recently earned the coveted Ethics Inside Certification from the Ethisphere Institute, a leading international think tank dedicated to the research and promotion of best practices in corporate ethics and compliance, and is the only health care GPO to earn this distinction.

Contact:

Brent Johnson
IRadimed Corporation
(407) 677-8022 Ext. 115
[email protected]

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.

SOURCE IRadimed Corporation